α-protein kinase 3 (αPK3) inhibitors represent a class of compounds that specifically target the activity of α-protein kinase 3, an enzyme belonging to the atypical protein kinase family. αPK3, like other atypical protein kinases, diverges from the conventional kinase domain structure typically observed in the serine/threonine and tyrosine kinases, which is one of the reasons for its unique functional characteristics. The enzyme plays a critical role in phosphorylating specific protein substrates, regulating a variety of intracellular processes such as signal transduction pathways, protein-protein interactions, and cellular structural dynamics. The inhibitors in this class exert their action by binding to the active or allosteric sites of αPK3, interfering with its ability to transfer phosphate groups to its target proteins. These inhibitors can exhibit high selectivity due to the distinctive structural motifs found in the kinase domain of αPK3, making them essential tools for studying its function in biochemical and biophysical research.
The chemical structures of αPK3 inhibitors are often designed to interact with key residues within the kinase's ATP-binding pocket or other regulatory regions that control its catalytic activity. Structural studies of these inhibitors have revealed that many employ competitive inhibition mechanisms, but non-competitive or allosteric inhibition is also observed. Understanding the molecular interactions between αPK3 and its inhibitors is fundamental for elucidating the enzyme's role in complex cellular processes. Through techniques such as X-ray crystallography, computational modeling, and mutagenesis studies, researchers are able to dissect the fine details of how these inhibitors achieve specificity and potency, contributing to a broader understanding of kinase signaling networks. By modulating αPK3 activity, researchers can better explore the kinase's involvement in cell growth, differentiation, and response to environmental stimuli, thereby advancing the knowledge of its fundamental biological roles.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum kinase inhibitor which can inhibit various protein kinases, possibly affecting α-protein kinase 3. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Targets multiple kinases, and could indirectly influence α-protein kinase 3 functionality. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Inhibits several kinases; its activity might affect pathways involving α-protein kinase 3. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $193.00 $510.00 $1072.00 | 4 | |
A multi-targeted kinase inhibitor, which can potentially interfere with α-protein kinase 3-associated pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
A broad kinase inhibitor; its spectrum of inhibition could encompass pathways related to α-protein kinase 3. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Designed for certain kinases; its activity might intersect with α-protein kinase 3 functions. | ||||||
Vemurafenib | 918504-65-1 | sc-364643 sc-364643A | 10 mg 50 mg | $115.00 $415.00 | 11 | |
Targets specific kinases; might have implications for pathways involving α-protein kinase 3. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits vacuolar ATPases, which might indirectly affect cellular processes linked with α-protein kinase 3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, possibly impacting downstream signaling pathways associated with α-protein kinase 3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which might indirectly modulate pathways or processes in which α-protein kinase 3 participates. |